US Patent Issued to Signal Rx Pharmaceuticals on March 17 for "Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors" (Arizona, North Carolina, Florida Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,254, issued on March 17, was assigned to Signal Rx Pharmaceuticals Inc..

"Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors" was invented by Guillermo A. Morales (Oro Valley, Ariz.), Joseph R. Garlich (Cape Coral, Fla.) and Donald L. Durden (Charlotte, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to compounds and methods of treating diseases including but not limited to, cancer, non-cancer proliferative disease, sepsis, autoimmune disease, viral infection, atherosclerosis, Type 1 or 2 diabetes, obesity, inflammatory disease, or Myc-dependent disorder including by modulating biological...